All terms in BAO
| Label | Id | Description |
|---|---|---|
| anteroseptal myocardial infarction | DOID_5855 | |
| transsexualism | DOID_10919 | [A gender identity disorder that is characterized by an individual's identification with a gender inconsistent or not culturally associated with their biological sex.] |
| gender identity disorder | DOID_1234 | [A disease of mental health that involves a conflict between a person's actual physical gender and the gender that person identifies himself or herself as.] |
| breast lymphoma | DOID_5826 | |
| breast cancer | DOID_1612 | [A thoracic cancer that originates in the mammary gland.] |
| endometrioid ovary carcinoma | DOID_5828 | |
| ovary adenocarcinoma | DOID_3713 | [An ovarian carcinoma that derives_from epithelial cells of glandular origin.] |
| EC 4.4.1.14 (1-aminocyclopropane-1-carboxylate synthase) inhibitor | CHEBI_136984 | |
| EC 3.5.1.98 (histone deacetylase) inhibitor | CHEBI_61115 | |
| EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor | CHEBI_76807 | |
| sickle cell anemia | DOID_10923 | |
| composite lymphoma | DOID_5820 | [A lymphoma that begins in cells of the immune system in which different types of lymphoma cells occur at the same time.] |
| B-cell lymphoma | DOID_707 | [A non-Hodgkin lymphoma that has_material_basis_in B cells.] |
| gray zone lymphoma | DOID_5822 | [A lymphoma that is characterized by having cellular features of both classic Hodgkin's lymphomas and large B-cell Lymphomas.] |
| EC 3.1.1.4 (phospholipase A2) inhibitor | CHEBI_50469 | |
| EC 3.1.1.* (carboxylic ester hydrolase) inhibitor | CHEBI_76773 | |
| extragonadal seminoma | DOID_5838 | |
| borderline personality disorder | DOID_10930 | [A personality disorder that involves a prolonged disturbance of personality function characterized by depth and variability of moods.] |
| personality disorder | DOID_1510 | [A disease of mental health that involve long-term patterns of thoughts and behaviors that cause serious problems with relationships and work.] |
| translation | GO_0006412 | [The cellular metabolic process in which a protein is formed, using the sequence of a mature mRNA or circRNA molecule to specify the sequence of amino acids in a polypeptide chain. Translation is mediated by the ribosome, and begins with the formation of a ternary complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, which subsequently associates with the small subunit of the ribosome and an mRNA or circRNA. Translation ends with the release of a polypeptide chain from the ribosome.] |